In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody.
Saved in:
| Title: | In vivo affinity and target engagement in skin and blood in a first-time-in-human study of an anti-oncostatin M monoclonal antibody. |
|---|---|
| Authors: | Reid J; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK., Zamuner S; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK., Edwards K; Statistics, GlaxoSmithKline, Stevenage, UK., Rumley SA; Clinical Platforms and Sciences, GlaxoSmithKline, Stevenage, UK., Nevin K; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK., Feeney M; Biopharm Research, GlaxoSmithKline, Stevenage, UK., Zecchin C; Clinical Pharmacology, GlaxoSmithKline, Stevenage, UK., Fernando D; Clinical Unit Cambridge, GlaxoSmithKline, Cambridge, UK., Wisniacki N; ImmunoInflammation, GlaxoSmithKline, Stevenage, UK. |
| Source: | British journal of clinical pharmacology [Br J Clin Pharmacol] 2018 Oct; Vol. 84 (10), pp. 2280-2291. Date of Electronic Publication: 2018 Jul 12. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
